Intrasense

Equities

ALINS

FR0011179886

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 07:58:33 2024-04-23 am EDT			5-day change	1st Jan Change
0.326 ^EUR	-1.21%		+7.59%	-9.44%

Apr. 17	Intrasense: an innovative solution for cancer monitoring	CF
Apr. 09	Guerbet: CE certificate for a platform	CF

Intrasense SA Reports Earnings Results for the Half Year Ended June 30, 2022

October 12, 2022 at 04:14 pm EDT

Intrasense SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 1.91 million compared to EUR 1.81 million a year ago. Net loss was EUR 1.94 million compared to EUR 0.664 million a year ago.

Latest news about Intrasense

Intrasense: an innovative solution for cancer monitoring	Apr. 17	CF
Guerbet: CE certificate for a platform	Apr. 09	CF
Intrasense: awarded CE certificate	Apr. 09	CF
Invest Securities Raises Intrasense PT, Maintains Neutral Rating	Mar. 22	MT
INTRASENSE : Invest Securities adjusts its target	Mar. 22	CF
Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
CAC40: gloomy end to the week, timid weekly gain (+0.7%)	Feb. 09	CF
Intrasense: 2023 sales down on China	Feb. 09	CF
Guerbet: sales growth of 4% by 2023	Feb. 09	CF
Intrasense Partners with Software Company EDL for Myrian Distribution	23-10-19	MT
Intrasense S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-14	CI
Invest Securities Downgrades Intrasense to Neutral from Buy	23-08-04	MT
Guerbet SA completed the acquisition of 17.82% stake in Intrasense SA.	23-06-04	CI
Global markets live: Micron, Qantas, Zoom, Meta, BT Group...	23-05-23
Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Guerbet SA launched a takeover bid to acquire remaining 61.32% stake in Intrasense SA for ?14 million.	23-02-21	CI
Guerbet to Launch Voluntary Tender Offer for Intrasense After Acquiring 39% Stake	23-01-11	MT
Intrasense SA announced that it has received €8.8 million in funding from Guerbet SA	23-01-10	CI
Intrasense SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-12	CI
Intrasense SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-12	CI
Intrasense SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-10	CI
Intrasense SA Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-22	CI
Global markets live: Ryanair, Hyundai, Adecco, Goldman Sachs, JD.com...	21-09-07
Global markets live: Microsoft, Morgan Stanley, Heineken, Twitter, AstraZeneca...	21-06-23
Intrasense : Targets $6 Million in Rights Offering	21-05-24	MT

Chart Intrasense

Duration

Period

More charts

Company Profile

Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1,000 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner...). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-10 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INTRASENSE	-9.44%	18.34M
THERMO FISHER SCIENTIFIC	+8.35%	209B
DANAHER CORPORATION	+9.41%	175B
INTUITIVE SURGICAL, INC.	+11.75%	131B
BOSTON SCIENTIFIC CORPORATION	+19.34%	99.98B
SIEMENS HEALTHINEERS AG	-0.84%	61.12B
EDWARDS LIFESCIENCES CORPORATION	+15.08%	52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-2.10%	46.5B
AGILENT TECHNOLOGIES, INC.	+0.10%	39.24B
GE HEALTHCARE TECHNOLOGIES INC.	+11.50%	38.47B

Other Advanced Medical Equipment & Technology